David Kerr

Current

• Senior Investigator
  Diabetes Research and Digital Health Equity,
  Sutter Center for Health Systems Research
• Adjunct Professor, Dept Electrical and Computer Engineering, Rice University
• Scientific Advisory Board, PATHS-UP (https://pathsup.org)
• Co-Chair, Innovation sub-group
  NIDDK Working Group of Council
  Heterogeneity of Diabetes

Previously

• Research Committee, Association of Diabetes Care and Education Specialists
• Director of Research and Innovation, Sansum Diabetes Research Institute
• Consultant Physician, Bournemouth Diabetes and Endocrine Center, UK

Interests

• Digital Health
• Food-as-Medicine
• Health Equity

Recent Publications & Media

• Podcast: https://diabetestechnology.org/podcast/
• Media: New York Times – April 4, 2022
• Podcast: https://thehuddle.simplecast.com/episodes/glycemic-risk-index
• Book: Klonoff D, Kerr D and Espinoza J, Editors: Diabetes, Digital Health, Telehealth and Artificial Intelligence. Bioscience & Translational Medicine, Elsevier June 2024, ISBN: 9780443132445, eBook ISBN: 9780443132438
  Klonoff D, Kerr D and Weismann E. Editors: Diabetes Digital Health and Telehealth. Bioscience & Translational Medicine, Elsevier, July 2022, ISBN: 9780323905572, eBook ISBN: 9780323906760
  Klonoff D, Kerr D and Mulvaney S. Editors: Diabetes Digital Health. Bioscience & Translational Medicine Elsevier April 2020, ISBN: 9780128174852
• Award Lecture “Digital Health and Diabetes – Access, Trust and Self-Efficacy” – Issued by International Diabetes Federation · Dec 2022.  IDF [0000032510] LI2022-CTT14-Award Lecture from COVR (info) on Vimeo

Research

• Kerr D, Ahn D, Waki K, Wang J, Breznen B, Klonoff DC. Digital Interventions for Self-Management of Type 2 Diabetes Mellitus: Systematic Literature Review and Meta-Analysis. Journal of Medical Internet Research. 2024 Jul 22;26:e55757. doi: 10.2196/55757. https://www.jmir.org/2024/1/e55757
• Piette JD, Lee KCS, Bosworth HB, Isaacs D, Cerrada CJ, Kainkaryam R, Liska J, Lee F, Kennedy A, Kerr D. Behavioral Engagement and Activation Model Study (BEAMS): A latent class analysis of adopters and non-adopters of digital health technologies among people with Type 2 diabetes. Translational Behavioral Medicine. 2024 Jul 2:ibae034. doi: 10.1093/tbm/ibae034. https://academic.oup.com/tbm/article/14/8/491/7702719
• Simonson GD, Criego A, Battelino T, Carlson AL, Choudhary P, Franc S, Gershenoff D, Grunberger G, Hirsch IB, Isaacs D, Johnson M, Kerr D, et al. Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens. Diabetes Technol Ther. 2024 May 17. doi: 10.1089/dia.2024.0107.
• Klonoff DC, Kim SH, Galindo RJ, Joseph JI, Garrett V, Gombar S, Aaron RE, Tian T, Kerr D. Risks of peri- and postoperative complications with glucagon-like peptide-1 receptor agonists. Diabetes Obes Metab. 2024 May 14. doi: 10.1111/dom.15636. https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15636
• Tian T, Aaron RE, DuNova AY, Jendle JH, Kerr D, et al. Diabetes Technology Meeting 2023. J Diabetes Sci Technol. 2024 Mar 25:19322968241235205. doi: 10.1177/19322968241235205. https://journals.sagepub.com/doi/10.1177/19322968241235205?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
• Klonoff DC, Aaron RE, Tian T, DuNova AY, Pandey A, Rhee C, Fleming GA, Sacks DB, Pop-Busui R, Kerr D. Advanced Glycation Endproducts: A Marker of Long-term Exposure to Glycemia. J Diabetes Sci Technol. 2024 Mar 25:19322968241240436. doi: 10.1177/19322968241240436. https://journals.sagepub.com/doi/10.1177/19322968241240436?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
• Kerr D, Rajpura JR, Namvar T. Evaluating Patient and Provider Preferences for a Once-Weekly Basal Insulin in Adults with Type 2 Diabetes. Patient Prefer Adherence. 2024 Feb 14;18:411-424. https://www.dovepress.com/evaluating-patient-and-provider-preferences-for-a-once-weekly-basal-in-peer-reviewed-fulltext-article-PPA
• Pai A, Santiago R, Glantz N, Bevier W, Barua S, Sabharwal A and Kerr D. Multimodal digital phenotyping for meal characterization in Hispanic/Latino adults with or at risk of type 2 diabetes. NPJ Digital Medicine. 2024; 7: 7: https://doi.org/10.1038/s41746-023-00985-7
• Kalyani R, Allende-Vigo M, Antinori-Lent, Close K, Das S, Deroze P, Edelman S, El Sayed N, Kerr D, Neumiller J and Norton A. Prioritizing patient experiences in the management of diabetes and its complications: An Endocrine Society Position Statement. Journal of Clinical Endocrinology and Metabolism. 2024; Feb 21st: 1-24. https://doi.org/10.1210/clinem/dgad745
• Barua S, Sabharwal A, Glantz N, Conneely C, Larez A, Bevier W and Kerr D. A probabilistic reimagination of the dawn phenomenon. Insights from continuous glucose monitoring in an underserved population. Nature Scientific Reports. 2024 Feb 5; 14(1): 2915. https://www.nature.com/articles/s41598-024-52461-1
• Ebekozien O, Fantasia K, Farnoosh F, Sabharwal A and Kerr D. Technology and health inequities in diabetes care: How do we widen access to underserved populations & utilize technology to improve outcomes for all? Diabetes Obesity & Metabolism. 2024; Jan 31: https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15470
• Kerr D, Duncan I, Repetto E, Maroun R, Wu A, Perkins C, Bergman G and Giorgino F. Cost Analysis of Self-Monitoring Blood Glucose in Non Intensively Managed Type 2 Diabetes . American Journal of Managed Care. 2023: 29: 12.
• Tian T, Aaron RE, Huang J, Yeung AM, Svensson J, Gentile S, Forbes A, Heinemann L, Seley J, Kerr D, Klonoff D. Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society. J Diabetes Sci Technol. 2023 Aug 9th:19322968231187661.
• Sato E, Sabharwal A, Conneely C, Glantz N, Bevier W, Barua S, Pai A, Larez A and Kerr D. Farming for Life: Temporal changes in glycemia following a medical produce prescription program for predominantly Mexican American adults. Helyion Cell Press 2023; July 20^th
• J, Yeung AM, Klonoff DC, Abdel-Malek A, Ahn DT, Kerr D. People with Diabetes Using Insulin Flying Across Multiple Time Zones – Limitations and Opportunities for Diabetes Technologies. Endocrine Practice. 2023 Jul 15:S1530-891X(23)00472-X. doi: 10.1016/j.eprac.2023.07.003.
• Klonoff DC, Yeung AM, Huang J, Espinoza JC, Raymond JK, Lee WA, Koliwad SK, Kerr D. Twenty-first century management of diabetes with shared telemedicine appointments. Journal of Telemedicine and Telecare. 2023 Jul 20:1357633X231184503. doi: 10.1177/1357633X231184503.
• Duncan I, Kerr D, Aggarwal R, Huynh N. New Drugs for Obesity, Is the Excitement Affordable? Popul Health Manag. 2023 Jun 5. doi: 10.1089/pop.2023.0086.
• Yeung AM, Huang J, Pandey A, Hashim IA, Kerr D, et al. Biomarkers for the diagnosis of heart failure in people with diabetes: A consensus report from diabetes technology society. Progress in Cardiovascular Disease. 2023 May 11th.
• Huang J, Yeung AM, Kerr D, et al. Lipohypertrophy and Insulin. An Old Dog that Needs New Tricks. Endocrine Practice. 2023 Apr 23.
• Klonoff DC, Kerr D, Clark L. Barriers and Solutions to Trends and Disparities in Glycemic Control and Severe Hyperglycemia Among US Adults With Diabetes Using Insulin From 1988 to 2020. J Diabetes Sci Technol. 2023 Feb 17th.
• Huang J, Yeung AM, Kerr D, Klonoff DC. Using ChatGPT to Predict the Future of Diabetes Technology. J Diabetes Sci Technol. 2023 Feb 17th.
• Kerr D, Klonoff DC, Bergenstal RM, Choudhary P, Ji L. A Roadmap to an Equitable Digital Diabetes Ecosystem. Endocrine Practice. 2022 Dec 28: S1530-891X(22)00908-9.
• Kerr D, et al. New Digital Health Technologies for Insulin Initiation and Optimization for People With Type 2 Diabetes. Endocrine Practice. 2022 Aug;28(8):811-821
• Kerr D, Klonoff D. Breakthrough technology for in-hospital glucose monitoring. Lancet Diabetes Endocrinology. 2022 May;10(5):304-306.
• Kerr D, et al. Patterns of Timing and Intensity of Physical Activity and HbA1c Levels in Hispanic/Latino Adults With or at Risk of Type 2 Diabetes. J Diabetes Sci Technol. 2022 Jun 30:19322968221105531.
• Kerr D, et al. A persisting parallel universe in diabetes care within America’s capital. Lancet EClinicalMedicine. 2021 Dec 24;43:101244